New Research Poster 2 (open)
New Research Posters Session 2

Thursday, October 29, 2015: 10:00 AM-12:30 PM
 
2.1
Behavioral and Neural Mechanisms Related to Antipsychotic-Induced Weight Gain
Jacqueline M. Buchanan, BA Columbia University College of Physicians and Surgeons, New York, NY
Ana Fernandes, PhD Champalimaud Neuroscience Programme, Champalimaud Foundation, Lisbon Portugal
Jonathan A. Slater, MD Columbia University College of Physicians and Surgeons, Irvington, NY
Rui M. Costa, PhD Champalimaud Neuroscience Programme, Champalimaud Foundation, Lisbon Portugal
Albino Oliveira-Maia, MD, MPH, PhD Champalimaud Neuroscience Programme, Champalimaud Foundation, Lisbon Portugal
 
2.2
Magnetic Resonance Imaging of Fat Deposition in Adolescents With First-Time Use of Antipsychotics
Araba Chintoh, MBBS, PhD University of Toronto, Toronto, ON
Gary Remington, MD, FRCPC, PhD Centre for Addiction and Mental Health, Toronto, ON
Margaret Hahn, MD, PhD Centre for Addiction and Mental Health, Toronto, ON
 
2.3
Characterization of Deficits in Social Emotional Cognition in Low Weight Adolescent Eating Disorders
Emily K. Gray, MD Eating Disorders Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Franziska Plessow, PhD Harvard Medical School and Beth Israel Deaconess Medical Center, Boston, MA
Helen B. Burton, BA Eating Disorders Clinical and Research Program, Massachusetts General Hospital, Boston, MA
Christopher J. Mancuso, BS Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA
Laura Germine, PhD Psychiatric and Neurodevelopmental Genetics Unit, Massachusetts General Hospital; Harvard Medical School, Boston, MA
Jennifer J. Thomas, PhD Eating Disorders Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA
Meghan Slattery Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA
Christiane Tolley Neuroendocrine Unit, Massachusetts General Hospital, Boston, MA
Charumathi Baskaran, MD Massachusetts General Hospital and Harvard Medical School, Boston, MA
Madhusmita Misra, MD Harvard Medical School, Boston, MA
Elizabeth A. Lawson, MD Harvard Medical School and Massachusetts General Hospital, Boston, MA
Kamryn E. Eddy, PhD Eating Disorders Clinical and Research Program, Massachusetts General Hospital and Harvard Medical School, Boston, MA
 
2.4
Understanding the Effect of Exposure to Prevention Programming on Adolescent Substance Use Disorders: A National and Statewide Multivariate Comparison
Justine Wittenauer, MD Cambridge Health Alliance and Harvard Medical School, Somerville, MA
Sherry Shu-Yeu Hou, MPH Cambridge Health Alliance, Somerville, MA
Benjamin Cook, MPH, PhD Cambridge Health Alliance, Somerville, MA
 
2.5
The Relationship Between Parental-Childhood Extra-Familial Adversity and Offspring Psychopathology
Kerry O'Loughlin, BA The University of Vermont, Burlington, VT
Hannah M. Holbrook, BA University of Vermont at Burlington, Burlington, VT
Joan Kaufman, PhD University of Vermont at Burlington, Burlington, VT
Robert R. Althoff, MD, PhD University of Vermont, Burlington, VT
Masha Y. Ivanova, PhD University of Vermont College of Medicine, Burlington, VT
Catherine Orr, PhD Vermont Center for Children, Youth, and Families, Burlington, VT
Matthew D. Albaugh, PhD University Health Center, Burlington, VT
James J. Hudziak, MD Vermont Center for Children, Youth, and Families, Burlington, VT
 
2.6
Offspring of Bipolar Patients From the U.S. Are More Ill Than European Offspring
Robert M. Post, MD Bipolar Collaborative Network, Bethesda, MD
Lori L. Altshuler, MD David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA
Ralph Kupka, MD VU University Medical Center, Amsterdam Netherlands
Susan McElroy, MD Lindner Center of HOPE, Mason, OH
Mark Frye, MD Mayo Clinic, Rochester, MN
Michael Rowe, PhD Bipolar Collaborative Network, Bethesda, MD
Gabriele Leverich, MSW Bipolar Collaborative Network, Bethesda, MD
Heinz Grunze, MD Newcastle University, Newcastle upon Tyne United Kingdom
Trisha Suppes, MD Stanford University School of Medicine, Stanford, CA
Paul E. Keck, MD Lindner Center of HOPE, Mason, OH
Robert L. Findling, MD, MBA The Johns Hopkins University, Baltimore, MD
Willem A. Nolen, MD, PhD University Medical Center Groningen, Groningen Netherlands
 
2.7
Evaluation of the Validity of an Ecologically-Valid Test in a Clinical Sample of Children and Adolescents With ADHD
Marcos Rosetti , Mexico City Mexico
Robyn Hudson, PhD Universidad Nacional Autonoma de Mexico, Mexico Mexico
Rosa E. Ulloa, MD, PhD Child Psychiatric Hospital, Mexico City Mexico
Alejandro Monterrosas Child Psychiatric Hospital, Mexico City Mexico
Homero David Sandoval, MD Hospital Psiquiatrico Infantil Dr. Juan N. Navarro, Mexico City Mexico
 
2.8
Psychosocial Functioning, Health, and Well-Being in Juvenile Diabetes
Susan Samuels, MD New York Psychiatric Institute and Columbia University Medical College, New York, NY
Zoltan Antal, MD New York Presbyterian Hospital and Weill Cornell Medical College, New York, NY
Tara Mathews, PhD New York Presbyterian Hospital and Weill Cornell Medical College, New York, NY
Darya Terekhova, PhD Weill Cornell Medical College, New York, NY
Elizabeth Madva, MD Massachusetts General Hospital McLean Adult Psychiatry Residency Program, Boston, MA
Elizabeth Mauer, MS Weill Cornell Medical College, New York, NY
Sasha Hernandez, BS Weill Cornell Medical College, New York, NY
Ashly Cochran, MS Weill Cornell Medical College, New York, NY
Michelle Tricamo, MD Weill Cornell Medical Center, New York, NY
 
2.9
Executive Functioning Vulnerabilities in Youth at Risk for Major Mood Disorders
Manpreet K. Singh, MD Stanford University School of Medicine, Menlo Park, CA
Kathryn R. Goffin, BA Stanford University School of Medicine, Stanford, CA
Saloni Shah, BA Stanford University School of Medicine, Stanford, CA
Cameron Backes Stanford University School of Medicine, Stanford, CA
Daniella DeGeorge, BA Stanford University School of Medicine, Stanford, CA
Jessica Maya Hernandez, BA Stanford University School of Medicine, Stanford, CA
Amy Garrett, PhD Stanford University, Palo Alto, CA
Kiki Chang, MD Stanford University, Palo Alto, CA
 
2.10
Disruptive Mood Dysregualtion Symptoms and Sleep Problems in Community and Clinical Pediatric Samples
James Waxmonsky, MD Penn State College of Medicine, Hershey, PA
Susan D. Mayes, PhD Penn State Hershey College of Medicine, Hershey, PA
Susan L. Calhoun, PhD Penn State Hershey College of Medicine, Hershey, PA
Julio Fernandez-Mendoza, PhD Penn State College of Medicine, Hershey, PA
Edward Bixler, PhD Penn State College of Medicine, Hershey, PA
 
2.11
Characterization of Problem Behavior in Phelan-McDermid Syndrome Compared to Idiopathic Autism Spectrum Disorder Using the Aberrant Behavior Checklist
Erin Li, BA Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
Teresa Tavassoli, PhD Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
Stacey Lurie, BA Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
Alexa Mieses, BS Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
Paige M. Siper, PhD Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
A. Ting Wang, PhD Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
Alexander Kolevzon, MD Icahn School of Medicine at Mount Sinai and Seaver Autism Center, New York, NY
 
2.13
The Effects of Small Birth Weight for Gestational Age and Polymorphisms of the Dopamine D4 Receptor Gene on Attachment Styles of Preschool Children
Justin Graffi, BS McGill University, Montreal, QC
Ellen Moss, PhD University of Quebec at Montreal, Montreal, QC
Alexis Jolicoeur-Martineau, MSC Jewish General Hospital, Montreal, Montreal, QC
Gal Moss, BS Hebrew University of Jerusalem, Jerusalem Israel
Vanessa Lecompte, PhD University of Quebec at Montreal, Montreal, QC
Katherine Pascuzzo, PhD University of Quebec at Montreal, Montreal, QC
Vanessa Babineau, PhD McGill University, Montreal, QC
Cathryn Gordon-Green, PhD McGill University, Montreal, QC
Viara Mileva-Seitz, PhD Leiden University, Leiden Netherlands
Klaus Minde, MD McGill University, Westmount, QC
Roberto Sassi, MD, PhD McMaster University, Hamilton, ON
Normand Carrey, MD Dalhousie, Halifax, NS
James Kennedy, MD, FRCP, MSC Centre for Addiction and Mental Health, Toronto, ON
Helen Gaudreau, PhD McGill University, Montreal, QC
Roberto Levitan, MD University of Toronto, Toronto, ON
Michael Meaney, PhD Douglas Institute, Montreal, QC
Ashley Wazana, MD Jewish General Hospital, Montreal, Montreal, QC
 
2.14
Assessing Mental Health First Aid USA: Measurement Development and Impact of a Mental Health Education Program
My Banh, PhD Georgetown University School of Medicine, Washington, DC
Irene Yoon, MPH Georgetown University Center for Child and Human Development, Washington, DC
Jeremy Chaikind, BS Georgetown University Center for Child and Human Development, Washington, DC
Sybil Goldman, MSW Georgetown University Center for Child and Human Development, Washington, DC
Bruno Anthony, PhD Georgetown University Center for Child and Human Development, Washington, DC
 
2.15
Overweight/Obesity and Use of Video Games and Computers in a Clinical Sample of Hispanic Adolescents, 2014-2015
Luz N. Colon-de MartÌ, MD University of Puerto Rico School of Medicine, San Juan, PR
Lelis L. Nazario-Rodriguez University of Puerto Rico, Medical Sciences Campus, San Juan, PR
Linnette Rodriguez-Figueroa, PhD University of Puerto Rico School of Public Health, San Juan, PR
 
2.16
Implementation of Incentive-Based Electronic Exercise Intervention in a Clinical Setting
Stephanie K. Day, BA University of Vermont College of Medicine, Burlington, VT
Samuel Raszka University of Vermont, Burlington, VT
Casey Winterson University of Vermont, Burlington, VT
Matthew D. Albaugh, PhD University of Vermont, Burlington, VT
Eco de Geus, PhD Vrije Universiteit, Amsterdam Netherlands
Meike Bartels, PhD Vrije Universiteit, Amsterdam Netherlands
Jeremy Sibold, EdD University of Vermont, Burlington, VT
Robert R. Althoff, MD, PhD University of Vermont, Burlington, VT
James J. Hudziak, MD Vermont Center for Children, Youth, and Families, Burlington, VT
 
2.17
The Prevalence of Mental Illness and Psychosocial Risk Factors in a Rural Residential Cohort of Pregnant and Post-Partum Women With Co-Occurring Substance Use Disorders
Anilla Del Fabbro, MD University of New Mexico, Albuquerque, NM
Shawn S. Sidhu, MD University of New Mexico, Albuquerque, NM
Simerjeet Brar, MD University of New Mexico, Albuquerque, NM
Julie G. Salvador, PhD University of New Mexico, Albuquerque, NM
Caroline Bonham, MBBS, MS University of New Mexico, Albuquerque, NM
Annette Crisanti, PhD University of New Mexico, Albuquerque, NM
Danielle K. Duran, MS University of New Mexico, Albuquerque, NM
 
2.18
A 6-Week, Randomized, Multicenter, Double-Blind, Parallel, Flexed- and Fixed-Dose Study of MDX (Metadoxine Extended-Release; MG01CI) Compared With Placebo in Adolescents and Adults With Fragile X Syndrome
Elizabeth Berry-Kravis, MD Rush University Medical Center, Chicago, IL
Jonathan Rubin, MD, MBA Alcobra Pharma, Philadelphia, PA
Eran Harary, MD Alcobra Pharma, Tel Aviv Israel
Yaron Daniely, MBA, PhD Alcobra Pharma, Tel Aviv Israel
 
2.19
Lurasidone for the Treatment of Irritability Associated With Autistic Disorder
Matthew Brams, MD Baylor College of Medicine, Houston, TX
Robert L. Findling, MD, MBA The Johns Hopkins University, Baltimore, MD
Robert S. Goldman, PhD Sunovion Pharmaceuticals Inc., Marlborough, MA
Robert Silva, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
David Hernandez, BA Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Ling Deng, PhD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
Raymond Mankoski, MD, PhD Sunovion Pharmaceuticals Inc., Marlborough, MA
Antony Loebel, MD Sunovion Pharmaceuticals Inc., Fort Lee, NJ
 
2.20
Extended-Release Molindone (SPN-810) As Adjunctive Therapy in the Management of Impulsive Aggression in Children With ADHD Receiving Optimized Stimulant Monotherapy and Behavioral Therapy
Scott T. Brittain, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
Jennifer D. Stocks, MS Supernus Pharmaceuticals, Inc., Rockville, MD
Janet A. Johnson, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
Tesfaye Liranso, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
Robert L. Findling, MD, MBA The Johns Hopkins University, Baltimore, MD
 
2.21
Psychotropic Polypharmacy Patterns in Medicaid Recipients: Trends and Concerns
Regina Bussing, MD, MSHS University of Florida College of Medicine, Gainesville, FL
Xinyue Liu, BS University of Florida, Gainesville, FL
Juan Hincapie-Castillo, PharmD University of Florida, Gainesville, FL
Almut G. Winterstein, PhD University of Florida, Gainesville, FL
 
2.22
Do Tertiary Care Hospitals and Community SSRI, Antipsychotic, and Psycho-Stimulants Usage Patterns in Children and Adolescents Match the Evidence Base Guidelines?
Olivia G. Calancie, BS Hotel Dieu Hospital, Kingston, ON
Varinderjit D. Parmar, MD Queen's University, Kingston, ON
Sarosh K. Khan, MD Hotel Dieu Hospital, Kingston, ON
 
2.23
Vigabatrin in Patients With Treatment-Resistant Tourette's Disorder: A Proof-of-Concept Study
Barbara J. Coffey, MD, MS Icahn School of Medicine at Mount Sinai, New York, NY
Jonathan Brodie, MD, PhD NYU School of Medicine, New York, NY
Laura Ibanez, MA Icahn School of Medicine at Mount Sinai, New York, NY
Zoey Shaw, BA Icahn School of Medicine at Mount Sinai, New York, NY
Steven Miller, PhD Catalyst Pharmaceuticals, Coral Gables, FL
 
2.24
Efficacy and Safety of High-Dose Folinic Acid in Autism Spectrum Disorder: Open Label Follow-Up of a Randomized Controlled Trial
Leanna Delhey, BA Arkansas Children's Hospital Research Institute, Little Rock, AR
John Slattery, BA Arkansas Children's Hospital Research Institute, Little Rock, AR
Fnu Deepmala, MD University of Arkansas for Medical Sciences, Little Rock, AR
Billy Furgerson, PharmD Arkansas Children's Hospital, Little Rock, AR
Teru Strickland, PharmD Arkansas Children's Hospital, Little Rock, AR
Marie Tippett, BA Arkansas Children's Hospital Research Institute, Little Rock, AR
Angela Sailey, PhD Arkansas Children's Hospital, Little Rock, AR
Rebecca Wynne, MS Arkansas Children's Hospital, Little Rock, AR
Shannon Rose, PhD Arkansas Children's Hospital Research Institute, Little Rock, AR
Stepan Melnyk, MD Arkansas Children's Hospital Research Institute, Little Rock, AR
S. Jill James, PhD Arkansas Children's Hospital, Little Rock, AR
Jeffery Sequeira, MS SUNY Downstate Medical Center, Brooklyn, NY
Edward Quadros, PhD SUNY Downstate Medical Center, Brooklyn, NY
Richard Frye, MD, PhD Arkansas Children's Hospital Research Institute, Little Rock, AR
 
2.25
An Open-Label Pharmacokinetics and Safety Study of Vortioxetine in Pediatric Patients
Robert L. Findling, MD, MBA The Johns Hopkins University, Baltimore, MD
Adelaide S. Robb, MD Children's National Medical Center, Washington, DC
Melissa P. DelBello, MD, MS University of Cincinnati College of Medicine, Cincinnati, OH
Michael Huss, MD University of Medicine, Mainz Germany
Nora McNamara, MD University Hospitals Case Medical Center, Cleveland, OH
Elias Sarkis, MD Sarkis Family Psychiatry, Gainesville, FL
Russell Scheffer, MD University of Kansas School of Medicine-Wichita, Wichta, KS
Lis Poulsen H. Lundbeck A/S, 2500 Denmark
Grace Chen, PhD Takeda Development Center Americas, Inc., Deerfield, IL
Johan Areberg, PhD H. Lundbeck A/S, Valby Denmark
Philippe Auby, MD Lundbeck SAS, Cedex France
 
2.26
Treatment With Paliperidone Extended-Release Formulation for Children and Adolescents Presented With Anger Outsburst
Lee Fu-I, MD Clinica Dra Lee Fu I SS Ltda, São Paulo Brazil
Miguel A. Angelo Boarati, MD School of Medicine, University of São Paulo, São Paulo Brazil
 
2.27
Trends in Prescription of Concomitant ADHD Medications
Jaswinder K. Ghuman, MD Community Care Behavioral Health and University of Pittsburgh Medical Center, Sewickley, PA
Irina Karpov, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Meghna Parthasarathy, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Shari L. Hutchison, MS Community Care Behavioral Health Organization, Pittsburgh, PA
Kim Castelnovo Community Care Behavioral Health Organization, Pittsburgh, PA
James M. Schuster, MD Community Care Behavioral Health Organization, Pittsburgh, PA
 
2.28
Double-Blind, Randomized, Placebo-Controlled Study of Immediate-Release Viloxazine (SPN-812IR) as a Novel Non-Stimulant Therapy in Adults With ADHD
Janet A. Johnson, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
Keith Saylor, PhD NeuroScience Inc., Herndon, VA
Scott T. Brittain, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
Gabriela Tulloch Supernus Pharmaceuticals, Inc., Rockville, MD
Tesfaye Liranso, PhD Supernus Pharmaceuticals, Inc., Rockville, MD
 
2.29
An Exploratory Study of ADHD Response Relative to Plasma Levels of Buproprion and Metabolites
Larry D. Mitnaul Jr., MD, MPH, MS Dartmouth Hitchcock Medical Center, Enfield, NH
 
2.30
Time Course of the Effects of Lisdexamfetamine Dimesylate in Two Randomized, Double-Blind, Active- and Placebo-Controlled Trials in Adolescents With ADHD
Jeffrey H. Newcorn, MD Icahn School of Medicine at Mount Sinai, New York, NY
Peter Nagy, MD Vadaskert Child and Adolescent Psychiatry Hospital and Outpatient Clinic, Budapest Hungary
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Glen Frick, MD Shire, Wayne, PA
Brian Yan, PhD Shire, Wayne, PA
Lisa Politza, BS Shire, Wayne, PA
Steven R. Pliszka, MD University of Texas Health Science Center at San Antonio, San Antonio, TX
 
2.31
Atypical Antipsychotic Use for Non-Psychotic Conditions Among Publicly-Insured Children and Adolescents: A Multilevel Assessment of the Role of Multiple Diagnoses and Physician Specialty
Dinci Pennap, MPH University of Maryland, Baltimore, MD
George Unick, PhD University of Maryland, Baltimore, MD
 
2.32
Topiramate, Zonisamide, and Weight Loss in Children and Adolescents Prescribed Psychiatric Medications
Michael Shapiro, MD University of Florida, Gainesville, FL
Adam M. Reid, MS University of Florida, Gainesville, FL
Brian Olsen, PhD University of Florida, Gainesville, FL
Michael Taasan, MPH University of Florida, Gainesville, FL
Joseph McNamara, PhD University of Florida, Gainesville, FL
Mathew Nguyen, MD University of Florida, Gainesville, FL
 
2.33
Results From an Open-Label Trail of Olanzapine as Adjunctive Treatment for Anorexia Nervosa in Adolescents
Wendy Spettigue, MD Children's Hospital of Eastern Ontario, Ottawa, ON
Mark Norris, MD Children's Hospital of Eastern Ontario, Ottawa, ON
Katherine Henderson, PhD Anchor Psychological Associates, Ottawa, ON
Megan Harrison, MD Children's Hospital of Eastern Ontario, Ottawa, ON
Danijela Maras, MA University of Ottawa, Ottawa, ON
Rebecca Gomez, BS University of Ottawa, Ottawa, ON
Claire Lee, BS University of Ottawa, Ottawa, ON
Stephen Feder, MD Children's Hospital of Eastern Ontario, Ottawa, ON
 
2.34
No Apparent Cardiac Conduction Effects of Acute Treatment With Risperidone in Children With Autism
Lan Chi Krysti Le Vo, MD Emory University School of Medicine, Atlanta, GA
Courtney E McCracken, PhD Emory University, Atlanta, GA
Michael S. Kelleman, MPH Emory University, Atlanta, GA
Lawrence Scahill, PhD Emory University School of Medicine, Atlanta, GA
 
2.35
A Phase III Clinical Endpoint Evaluation of HLD200 in Children With ADHD: Safety Results
Sharon Wigal, PhD AVIDA Inc., Newport Beach, CA
Ann Catherine Childress, MD Center for Psychiatry and Behavioral Medicine, Inc., Las Vegas, NV
Mary Ann McDonnell, PhD South Shore Psychiatric Services, PC, Marshfield, MA
Scott H. Kollins, PhD Duke University Medical Center, Durham, NC
Floyd R. Sallee, MD, PhD University of Cincinnati, Edisto, SC
Norberto J. DeSousa, MA Ironshore Pharmaceuticals & Development, Inc., Grand Cayman Cayman Islands
 
2.36
What's in a Name?
Michael DiGiacomo, MD University at Buffalo School of Medicine, Buffalo, NY
Alex Cogswell, PhD University at Buffalo, Buffalo, NY
Melissa Pierre-Louis, BS University at Buffalo School of Medicine, Buffalo, NY
 
2.37
Implementation of the Vermont Family-Based Approach in Rural Community Mental Health Centers
James J. Hudziak, MD Vermont Center for Children, Youth, and Families, Burlington, VT
Daniel B. Hall, BS University of Vermont Medical Center, Vermont Center for Children Youth and Families, Burlington, VT
Masha Y. Ivanova, PhD University of Vermont College of Medicine, Burlington, VT
 
2.38
The Validity of the Swedish Scared-R Scale and Subscales
Tord Ivarsson, MD, PhD The Center for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo Norway
Gudmundur A. Skarphedinsson, PhD The Center for Child and Adolescent Mental Health, Eastern and Southern Norway, Oslo Norway
Markus Andersson Child and Adolescent Psychiatry Halland Sweden, Träslövsvägen 25 a Sweden
Hakan Jarbin, MD Lund University, Lund Sweden
 
2.39
Impact of Training Staff in Cognitive Behavioral Therapy for Psychosis (CBTp) Informed Interventions on the Milieu of an Early Psychosis Inpatient Psychiatric Unit
Sally E. Riggs, PhD Kings County Hospital Center, Brooklyn, NY
Mandeep Kaur, MD Kings County Hospital Center/SUNY Downstate Medical Center, Brooklyn, NY
Anbreen Khizar, MD Kings County Hospital Center/SUNY Downstate Medical Center, Brooklyn, NY
Lionel Pereira, MD Kings County Hospital Center/SUNY Downstate Medical Center, Brooklyn, NY
Roumen N. Nikolov, MD Kings County Hospital Center, Brooklyn, NY
 
2.40
An Interdisciplinary Approach to Suicide Risk Assessment: Development and Implementation Across a National Organizational Network
Megan M. Russell-Currie, PhD Devereux, Villanova, PA
Marilyn B. Benoit, MD Devereux, Villanova, PA
Susan Soldivera Kiesling, MS Devereux, Villanova, PA
Ashley Gadarowski, BA Devereux, Villanova, PA
Thomas Wasser, PhD Complete Statistical Services, Macungie, PA
Robert Nass, MA Devereux, Villanova, PA
Glynn Fraker, MS, RN Devereux, Villanova, PA
Jeremy Aho Devereux, Villanova, PA
 
2.41
The Psychotropic Medication Prescribing Trends in Foster Children of Georgia
Alka Aneja, MD, MA Department of Human Services, Atlanta, GA
Michael Fost, BA Department of Human Services, Atlanta, GA
Esha Aneja Department of Human Services, Atlanta, GA
 
2.42
Poster Docent: Increasing Utilization of the Emergency Department for Psychiatric Visits by the Pediatric Population
Sharon M. Holder, MSC, MSW, PhD Greenville Health System, Greenville, SC
Eunice Peterson, MD Greenville Health System, Greenville, SC
Dawn Blackhurst, DrPH Greenville Health System, Greenville, SC
Calvert Warren, MD Greenville Health System, Greenville, SC
Kenneth M. Rogers, MD Greenville Memorial Hospital, Greenville, SC
Christian Ochonma, MBBS, MPH Greenville Health System, Greenville, SC
 
2.43
Collaborative Child and Adolescent Psychiatry Within Primary Care Clinics in Coastal Louisiana
Kristopher Kaliebe, MD Louisiana State University Health Science Center, New Orleans, LA
Joy Osofsky, PhD Louisiana State University Health Science Center, New Orleans, LA
Howard Osofsky, MD Louisiana State University Health Science Center, New Orleans, LA
Lucy King, BA Louisiana State University Health Science Center, New Orleans, LA
Tonya Cross Hansel, PhD Louisiana State University Health Science Center, New Orleans, LA
 
2.44
Improving Behavioral Health Care in the Pediatric Medical Home
Katherine Marie Shea, MD, MPH Dartmouth-Hitchcock Medical Center, Lebanon, NH
Auden C McClure, MD, MPH Children's Hospital at Dartmouth, Lebanon, NH
Susan R. Pullen, MSW Dartmouth-Hitchcock Medical Center, Lebanon, NH
Karen A. Homa, DrPH Dartmouth-Hitchcock Medical Center, Lebanon, NH
Julie Balaban, MD Dartmouth-Hitchcock Medical Center, Lebanon, NH
 
2.45
Characterization of Patients Referred to a Child Psychiatrist Embedded in a Community Pediatrics Clinic
Andrea E. Spencer, MD Massachusetts General Hospital, Boston, MA
 
2.46
Poster Docent: Predictors of Prolonged Length of Stay in Emergency Child Psychiatry Visits
Anna K. Wiste, MD, PhD Massachusetts General Hospital, Boston, MA
Thomas H. McCoy, MD Massachusetts General Hospital, Boston, MA
Victor Castro, BS Massachusetts General Hospital, Charlestown, MA
Laura M. Prager, MD Massachusetts General Hospital, Boston, MA
Roy H. Perlis, MD, MSC Massachusetts General Hospital, Boston, MA
 
2.47
Antenatal and Postnatal Maternal Anxiety/Depression: Exploring the Influences on Early Mother-Infant Feeding Interactions
Loredana Lucarelli, PsyD University of Cagliari, Cagliari Italy
Gaia de Campora, PhD University of Cagliari, Cagliari Italy
Elisa DessÏ, PsyD University of Cagliari, Cagliari Italy
Federica Falco, PsyD University of Cagliari, Cagliari Italy
Cristina Sechi, PhD University of Cagliari, Cagliari Italy
Irene Chatoor, MD Children's National Medical Center, Washington, DC
 
2.48
Maternal and Paternal Anxiety/Depression and Difficult Temperament Outcome in Infant Offspring: A Follow-Up Study From Pregnancy to 3 Months Old Infants
Loredana Lucarelli, PsyD University of Cagliari, Cagliari Italy
Simona Di Folco, PhD University of Cagliari, Cagliari Italy
Cristina Sechi, PhD University of Cagliari, Cagliari Italy
Irene Chatoor, MD Children's National Medical Center, Washington, DC
 
2.49
Correlates of Paternal Anxiety During the Perinatal Period in Turkey
Koray Karabekiroglu, MD Ondokuz Mayis University, Samsun Turkey
Tuna Cak, MD Hacettepe University, Ankara Turkey
Ebru Kultur, MD Hacettepe University, Ankara Turkey
Mahmut CEM Tarakcioglu, MD Bakirkoy Yusuf Sadi Konuk Hospital, Kocaeli Turkey
Gokce N. Say, MD Ondokuz Mayis University, Samsun Turkey
 
2.50
The Relationship Between Parent Stress and Adaptive Behavior in Preschool-Aged Children
Alexis Clyde, PhD Children's Health, Children's Medical Center and University of Texas Southwestern Medical Center, Dallas, TX
Catherine Karni, MD University of Texas Southwestern Medical Center, Dallas, TX
Susan Gelphman, MS Children's Health, Children's Medical Center, Dallas, TX
Kristina Daily, OTR/L Children's Health, Children's Medical Center, Dallas, TX
 
2.51
Feasibility and Acceptability of Using the Early Childhood Screening Assessment to Identify Mental Health Problems in Pediatric Primary Care
Elise M. Fallucco, MD Nemours Children's Specialty Care, Jacksonville, FL
Emma Robertson Blackmore, PhD University of Florida College of Medicine, Jacksonville, FL
Carolina Bejarano, BS Nemours Center for Health Care Delivery Science, Jacksonville, FL
Tim Wysocki, PhD Nemours Center for Health Care Delivery Science, Jacksonville, FL
Chelsea Kozikowski, BA Nemours Center for Health Care Delivery Science, Jacksonville, FL
Robin Landy Nemours Center for Health Care Delivery Science, Jacksonville, FL
Mary Margaret Gleason, MD, FAAP Clinical Assistant Professor, New Orleans, LA
 
2.53
Maternal Smoking During Child's Preschool Years Predicts Problematic Parenting Practices
Mini Tandon, DO Washington University School of Medicine, St. Louis, MO
Julia D. Grant, PhD Washington University School of Medicine, St. Louis, MO
Joan L. Luby, MD Early Emotional Development Program, Division of Child Psychiatry, St. Louis, MO
Pamela Madden, PhD Washington University School of Medicine, Saint Louis, MO
Andrew Heath, D Phil Washington University School of Medicine, St. Louis, MO
 
2.54
Latino Children of Immigrants at Age 6: A Nested Case-Control Study of Risk Predictors and Mediators of Psychopathology, and the Immigrant Paradox, in a Community Cohort
Norah S. Wallace, BA Judge Baker Children's Center, Boston, MA
Marisa Hollinshead, BA Harvard University, Center for Brain Science, Boston, MA
Matias Irarr·zaval, MPH University of Chile, Santiago Chile
Claudio O. Toppelberg, MD Judge Baker Children's Center and Harvard Medical School, Boston, MA

See more of: New Research Poster
Copyright © 2015 - American Academy of Child Adolescent Psychiatry. All Rights Reserved.